Improved Monitor of Cancer Recurrence in Leukemia Patients Through New Protocol
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia to inform more effective treatment strategies.
Read MorePosted by Andy Lundin | Feb 8, 2022 | Leukemia |
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia to inform more effective treatment strategies.
Read MorePosted by Andy Lundin | Dec 28, 2021 | Cancer, Sequencing Systems |
NeoGenomics will use Thermo Fisher Scientific’s next-generation sequencing solution in a pharma-sponsored Phase 1 study of myeloid cancer.
Read MorePosted by Toni Mitchell | Sep 21, 2021 | Leukemia, Microbiology Instruments, Prenatal Testing |
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.
Read MorePosted by Chris Wolski | Sep 8, 2021 | Molecular Diagnostic Analyzers |
Mission Bio has announced two key improvements to the core capabilities of its Tapestri Platform for hematologic oncology (heme-onc) research.
Read MorePosted by Melanie Hamilton-Basich | Jul 27, 2021 | Cancer |
St. Jude Children’s Research Hospital investigators have demonstrated that comprehensive genomic sequencing of all pediatric cancer patients is feasible and essential to capitalize on the lifesaving potential of precision medicine.
Read More